| abstract |
IT REFERS TO A COMPOUND OF FORMULA I, WHERE THE SUBSTITUTE -Z-R IS IN A TARGET POSITION OR FOR THE FENILO GROUP; X IS SELECTED FROM -CN, -CH2OH, -CH2-O- (ALKYLOC1-C4), -C (O) OH, AMONG OTHERS; Y IS CH2, CH (OH), O, C = O, N, AMONG OTHERS; Z IS O, S, SO, SO2; m AND p ARE EACH 1-3, ON THE CONDITION THAT m + p IS EQUAL TO OR LESS THAN 4. THE PREFERRED COMPOUNDS ARE: DIMETHYL- {4- [3- (3-PYRROLIDIN-1-ILPROPOXI) PHENYL] TETRAHYDRO- PYRAN-4-ILMETIL} AMINE; 1- {3- [4- (4-DIMETHYLAMINOMETHYL-TETRAHYDRO-PYRAN-4-IL) -PHENOXY] -PROPYL} -PIPERIDIN-4-OL; 2- (1- {3- [4- (4-DIMETHYLAMINOMETHYLTETRAHYDROPYRAN-4-IL) PHENOXY] PROPYL} PIPERIDIN-4-IL) ETHANOL; AMONG OTHERS. IT ALSO REFERS TO A PHARMACEUTICAL COMPOSITION. SUCH COMPOUNDS ARE LINKS OF HISTAMINE H3 RECEPTORS UTIELS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS AND INFLAMMATORY DISORDERS |